By Bill Berkrot NEW YORK (Reuters) - Amgen Inc on Tuesday forecast 2015 earnings and revenue well ahead of Wall Street projections and announced plans to cut costs and increase returns to shareholders through a dividend increase and share repurchases. The world's largest biotechnology company, at a business update for analysts and investors in New York, said it was looking for 2015 adjusted earnings of $9.05 to $9.40 a share on revenue of $20.8 billion to $21.3 billion. Analysts, on average, were expecting earnings of $9.07 per share on revenue of $20. ...
via Health News Headlines - Yahoo News http://ift.tt/1tEw7X9
No comments:
Post a Comment